GLP-1 and health: Beyond weight loss in the Ozempic era (SACRAMENTO) This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss drugs, Wegovy and Zepbound
These medications can be expensive, and not all insurance plans cover them, which may limit your access
Use of dietary supplements by children and adolescents
A statistically significant increase in cancer was observed in rats receiving semaglutide at all dose levels (greater than 2X human exposure)
Here, we discuss recent breakthroughs in understanding the significance of ferroptosis in cancers, metabolic disorders, autoimmune disorders, genetic disorders, cardiovascular diseases, neurodegenerative diseases, and musculoskeletal diseases
It is hoped that ongoing trials like SUMMIT, which is investigating tirzepatide in participants with HFpEF and obesity, will provide more evidence on incretin-based medications in HFpEF